In AD, NF-κB is implicated in amyloid-beta plaque formation and tau hyperphosphorylation (Sun et al., 2022), while in PD, it contributes to dopaminergic neuron loss (Rivas-Arancibia et al., 2015). Here, NFKB1 is linked to Parkinson disease.